Value proposition

The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients.

Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.

medical devices, endomicroscopy, in vivo microscopy, cancer imaging, medtech, healthcare, patient management, AI, Patient Centric, Research and Development, Cellvizio, Confocal Laser Endomicroscopy, patient outcomes, early detection, health, and cancer detection